Therefore, targeting the Nrf2-ALDH2/PolG2 pathway can both alter mitochondrial respiration and inhibit mtDNA synthesis to disrupt mitochondrial homoeostasis and increase the sensitivity of AML cells to chemotherapy drugs. Here, POLG2 is linked to acute myeloid leukemia.